146 related articles for article (PubMed ID: 25355597)
1. TGFβ signaling in pancreatic ductal adenocarcinoma.
Zhang H; Liu C; Kong Y; Huang H; Wang C; Zhang H
Tumour Biol; 2015 Mar; 36(3):1613-8. PubMed ID: 25355597
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor β receptor signaling restrains growth of pancreatic carcinoma cells.
Zhao Z; Xi H; Xu D; Li C
Tumour Biol; 2015 Sep; 36(10):7711-6. PubMed ID: 25934336
[TBL] [Abstract][Full Text] [Related]
3. The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration.
Tjomsland V; Sandnes D; Pomianowska E; Cizmovic ST; Aasrum M; Brusevold IJ; Christoffersen T; Gladhaug IP
J Exp Clin Cancer Res; 2016 Jul; 35(1):122. PubMed ID: 27473228
[TBL] [Abstract][Full Text] [Related]
4. Aberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression.
Hasselluhn MC; Schmidt GE; Ellenrieder V; Johnsen SA; Hessmann E
Cell Death Dis; 2019 Jun; 10(6):446. PubMed ID: 31171768
[TBL] [Abstract][Full Text] [Related]
5. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
7. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma.
Maftouh M; Belo AI; Avan A; Funel N; Peters GJ; Giovannetti E; Van Die I
Oncotarget; 2014 Jul; 5(14):5335-49. PubMed ID: 24977327
[TBL] [Abstract][Full Text] [Related]
8. Restoration of Smad4 in BxPC3 pancreatic cancer cells attenuates proliferation without altering angiogenesis.
Yasutome M; Gunn J; Korc M
Clin Exp Metastasis; 2005; 22(6):461-73. PubMed ID: 16320109
[TBL] [Abstract][Full Text] [Related]
9. SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma.
Dardare J; Witz A; Merlin JL; Gilson P; Harlé A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429474
[TBL] [Abstract][Full Text] [Related]
10. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
[TBL] [Abstract][Full Text] [Related]
11. Augmented TGFβ receptor signaling induces apoptosis of pancreatic carcinoma cells.
Li C; Zhao Z; Zhou Z; Liu R
Tumour Biol; 2015 Apr; 36(4):2815-9. PubMed ID: 25476855
[TBL] [Abstract][Full Text] [Related]
12. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
[TBL] [Abstract][Full Text] [Related]
13. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
[TBL] [Abstract][Full Text] [Related]
14. Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma.
Sarkar S; Mandal C; Sangwan R; Mandal C
Endocr Relat Cancer; 2014 Feb; 21(1):113-25. PubMed ID: 24402132
[TBL] [Abstract][Full Text] [Related]
15. TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma.
Alvarez MA; Freitas JP; Mazher Hussain S; Glazer ES
J Gastrointest Cancer; 2019 Jun; 50(2):207-213. PubMed ID: 30891677
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
Warner DR; Greene RM; Pisano MM
FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
[TBL] [Abstract][Full Text] [Related]
18. (Pro)renin receptor is crucial for Wnt/β-catenin-dependent genesis of pancreatic ductal adenocarcinoma.
Shibayama Y; Fujimori T; Nguyen G; Hirose T; Totsune K; Ichihara A; Kitada K; Nakano D; Kobori H; Kohno M; Masaki T; Suzuki Y; Yachida S; Nishiyama A
Sci Rep; 2015 Mar; 5():8854. PubMed ID: 25747895
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the transforming growth factor beta (TGFbeta) pathway by interleukin-1beta is mediated through TGFbeta-activated kinase 1 phosphorylation of SMAD3.
Benus GF; Wierenga AT; de Gorter DJ; Schuringa JJ; van Bennekum AM; Drenth-Diephuis L; Vellenga E; Eggen BJ
Mol Biol Cell; 2005 Aug; 16(8):3501-10. PubMed ID: 15917296
[TBL] [Abstract][Full Text] [Related]
20. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.
Zhi X; Tao J; Xie K; Zhu Y; Li Z; Tang J; Wang W; Xu H; Zhang J; Xu Z
Cancer Lett; 2014 Apr; 346(1):104-13. PubMed ID: 24374017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]